A detailed history of Cornercap Investment Counsel Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 41,074 shares of TEVA stock, worth $887,198. This represents 0.23% of its overall portfolio holdings.

Number of Shares
41,074
Previous 64,514 36.33%
Holding current value
$887,198
Previous $1.05 Million 29.39%
% of portfolio
0.23%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$15.81 - $18.96 $370,586 - $444,422
-23,440 Reduced 36.33%
41,074 $740,000
Q2 2024

Aug 08, 2024

BUY
$12.78 - $17.4 $824,488 - $1.12 Million
64,514 New
64,514 $1.05 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.